Latest Asx News

FireFly Metals Ltd has announced a flow-through share offer aiming to raise approximately A$11.2 million, targeting Canadian investors to fund regional exploration drilling. This offer complements a broader capital raising strategy to advance development at the Ming Mine and other key projects.

PointsBet Holdings has secured Foreign Investment Review Board approval for MIXI Australia's proposed full acquisition, marking a key regulatory milestone in the takeover process.

BetMakers Technology Group has successfully raised $11.5 million through a share placement aimed at repaying debt and funding strategic growth initiatives, including a potential acquisition in Nevada.

Hazel Group Limited has temporarily paused trading of its securities on the ASX, signaling an impending announcement that investors will want to watch closely.

Peninsula Energy has resolved outstanding claims with its EPC contractor and is advancing a reset plan for its Lance uranium project, including revised production guidance and funding strategies.

Aureka Limited has raised $3 million through a share placement to accelerate exploration and secure land access at its key gold projects in Victoria, signalling strong investor confidence in its growth strategy.

Hawsons Iron Ltd has been reinstated to ASX trading following an announcement of a proposed capital raising, signaling renewed investor interest.

Hawsons Iron Limited is raising up to $1 million through a discounted Share Purchase Plan to fund critical project development while continuing strategic investor discussions.

Ragusa Minerals has terminated its binding agreement with Geopolymer Industries due to unmet conditions, reaffirming its commitment to the Burracoppin rare earths project and exploring fresh opportunities.

EV Resources Limited has finalized its acquisition of a 70% interest in the Los Lirios Antimony Mine in Oaxaca, Mexico, marking a strategic move to bolster critical mineral supply in the Americas. The company is advancing ore testing and plans to develop processing capabilities aligned with local community priorities.

Island Pharmaceuticals has reported encouraging Phase 2a/b trial results for ISLA-101, demonstrating meaningful reductions in dengue viral load and symptoms in humans. The findings support further clinical development of this antiviral candidate.

MPower Group has struck a deal to sell nearly all its renewable energy assets to Wollemi Energy Group for about $19 million, unlocking significant shareholder value and setting the stage for a strategic reset.